Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs
about
Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesionsAdjuvants: Classification, Modus Operandi, and LicensingSuccessful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulatorImiquimod: mode of actionActivation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice.The therapeutic potential of Toll-like receptor 7 stimulation in asthma.The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6.Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele).Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled studyResiquimod and other immune response modifiers as vaccine adjuvants.Discovery of immunopotentiatory drugs: current and future strategies.Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin.Imiquimod (Aldara cream)Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infectionEmerging therapies for herpes viral infections (types 1 - 8).Imiquimod 5% cream (Aldara).The small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer.Immune response modifiers--mode of action.The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.TLR7 and TLR8 as targets in cancer therapy.Resiquimod, a topical drug for viral skin lesions and skin cancer.Imiquimod Injection to Rabbit Vocal Folds: A Preliminary, Preclinical Investigation.Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets.Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.Imiquimod: potential risk of an immunostimulant.Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice.Imiquimod: modes of action
P2860
Q24656625-2F083F44-F5C2-4605-84B3-72B5A3E43BC9Q26747586-23D38E98-572E-494F-A84E-E374AF6873ABQ28203663-377836E9-9502-4F78-A1C5-2A468C6F0CD2Q28260444-374DC881-B76F-4D39-A733-281A4EA1D7B3Q30391956-51402AD6-6021-42C4-8BBB-8CFDAAD8BDF2Q33725167-AD06A6A8-09F5-4372-9A9F-A50BF19A739EQ33976658-7BB345C1-3E66-4198-AAB0-2BD8E07C2F84Q33983310-F41AB82B-DF87-453A-93C1-CFCE27382F2FQ34144914-A3367069-396F-43B0-B87B-860C51DF2208Q34700325-AE7D32E1-BB1D-4837-9964-EB7C700C1FA3Q35009482-0D63EEDD-4B24-4AE1-B657-8E6423A8D3CCQ35602225-151BE72F-ACA9-4838-85B8-86089B8F2F63Q35615421-7A1F364A-3353-4B87-ADB4-FBE37382090CQ35751196-3900070F-9BD3-496C-A42F-7E9731A51FBCQ35967376-2EC0E883-FAAA-4C25-AE8C-54FC1C3F41F1Q36181182-5DD8AA35-53FB-4962-96B0-4A6A6080395AQ36379372-F7252593-F330-4F23-8BC0-C62B5ECC7EE3Q36455993-22A9AD45-0573-4DBC-A365-C17B7E722A18Q37043678-0A1E52BF-27F3-4897-AF33-40EB4E717781Q37051014-43CD317C-6A77-4132-B84B-5333E06106D7Q38064483-DC5A6FE5-0881-4129-89FA-848DF2062680Q38973989-3753EDE5-B006-4039-AA2C-847ED04C8F8DQ40307299-72626237-009C-4D2E-9D3A-88A72EFE0B75Q40505199-24704BB9-EAB2-416A-8397-B329DF174C74Q42079485-096F2755-8637-44C1-A6B0-BE7E3A3D7D55Q42445719-95F57916-0A60-40C5-8FE3-D98FE3BF9A84Q42522976-6A1E3211-0266-4420-A33A-71001C37F8B5Q44833308-4384A09C-84F3-441A-AA31-10F730A600BDQ44990877-99F53252-0F8F-47DE-A335-D90113A3C228Q57487665-A90AD2B4-6D0A-42EB-A223-DAE8E9A13CC7
P2860
Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@ast
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@en
type
label
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@ast
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@en
prefLabel
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@ast
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@en
P2093
P2860
P356
P1476
Posttherapy suppression of gen ...... ry by imiquimod in guinea pigs
@en
P2093
C J Harrison
D I Bernstein
R L Miller
P2860
P304
P356
10.1128/AAC.38.9.2059
P407
P577
1994-09-01T00:00:00Z